Choi, Y.; Lee, S.; Kim, H.J.; Park, T.; Kwack, W.G.; Yang, S.; Chung, E.K.
State-of-the-Art Evidence for Clinical Outcomes and Therapeutic Implications of Janus Kinase Inhibitors in Moderate-to-Severe Ulcerative Colitis: A Narrative Review. Pharmaceuticals 2025, 18, 740.
https://doi.org/10.3390/ph18050740
AMA Style
Choi Y, Lee S, Kim HJ, Park T, Kwack WG, Yang S, Chung EK.
State-of-the-Art Evidence for Clinical Outcomes and Therapeutic Implications of Janus Kinase Inhibitors in Moderate-to-Severe Ulcerative Colitis: A Narrative Review. Pharmaceuticals. 2025; 18(5):740.
https://doi.org/10.3390/ph18050740
Chicago/Turabian Style
Choi, Yunseok, Suhyun Lee, Hyeon Ji Kim, Taemin Park, Won Gun Kwack, Seungwon Yang, and Eun Kyoung Chung.
2025. "State-of-the-Art Evidence for Clinical Outcomes and Therapeutic Implications of Janus Kinase Inhibitors in Moderate-to-Severe Ulcerative Colitis: A Narrative Review" Pharmaceuticals 18, no. 5: 740.
https://doi.org/10.3390/ph18050740
APA Style
Choi, Y., Lee, S., Kim, H. J., Park, T., Kwack, W. G., Yang, S., & Chung, E. K.
(2025). State-of-the-Art Evidence for Clinical Outcomes and Therapeutic Implications of Janus Kinase Inhibitors in Moderate-to-Severe Ulcerative Colitis: A Narrative Review. Pharmaceuticals, 18(5), 740.
https://doi.org/10.3390/ph18050740
